Selective serotonin reuptake inhibitors and myocardial infarction

Circulation

Volumn 104, Issue 16, 2001, Pages 1894-1898

  Sauer, William H ^a   Berlin, Jesse A ^a   Kimmel, Stephen E ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Depression; Drugs; Epidemiology; Myocardial infarction; Platelets; Serotonin uptake inhibitors

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SMOKING; THROMBOCYTE ACTIVATION;

EID: 0035899867     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4101.097519     Document Type: Article

References (36)

1. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans
2. Depression, psychotropic medication, and risk of myocardial infarction: Prospective data from the Baltimore ECA follow-up
3. Depression and 18-month prognosis after myocardial infarction
4. The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment
5. Selective serotonin reuptake inhibitors: Meta-analysis of efficacy and acceptability
6. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease
7. Cardiovascular effects of fluoxetine in depressed patients with heart disease
8. Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors
9. Platelet activation in depression and effects of sertraline treatment: An open-label study
10. Platelet reactivity in depressed patients treated with paroxetine: Preliminary findings
11. Paroxetine decreases platelet serotonin storage and platelet function in human beings
12. The use of antidepressant drugs in patients with heart disease
13. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial): Sertraline Anti-Depressant Heart Attack Trial
14. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents
15. Risk of acute myocardial infarction and use of nicotine patches in a general population
16. Diagnostic criteria for hospitalized acute myocardial infarction: The Minnesota experience
17. The impact of confounder selection criteria on effect estimation
18. A short questionnaire for the measurement of habitual physical activity in epidemiological studies
19. Is the use of psychotropic drugs associated with increased risk of ischemic heart disease?
20. Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease
21. The effect of clinical outcome on platelet G proteins of major depressed patients
22. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients
23. Platelet cytosolic calcium responses to serotonin in depressed patients and controls: Relationship to symptomatology and medication
24. Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline
25. Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients: Relationship to clinical improvement
26. 2 mobilization in platelets
27. Prolonged bleeding time in a patient treated with sertraline
28. Bleeding, a side effect of fluoxetine
29. Fluoxetine and bleeding in obsessive-compulsive disorder
30. Bleeding attributed to the intake of paroxetine
31. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: Population based case-control study
32. Collaborative overview of randomised trials of antiplatelet therapy-1: Prevention of death, myocardial infarction, stroke by prolonged antiplatelet therapy in various categories of patients
33. Preliminary report: Effect of encainide and flecamide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction